AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
Log in

NYSE:CLBCore Laboratories SEC Filings & 10K Form

$21.18
+1.39 (+7.02 %)
(As of 06/2/2020 02:54 PM ET)
Add
Compare
Today's Range
$19.91
Now: $21.18
$21.30
50-Day Range
$10.81
MA: $16.76
$20.59
52-Week Range
$6.68
Now: $21.18
$56.03
Volume527,079 shs
Average Volume869,234 shs
Market Capitalization$941.66 million
P/E RatioN/A
Dividend Yield0.20%
Beta3.05

SEC Filings

Core Laboratories (NYSE:CLB) SEC Filings

DateFilerForm TypeView
05/20/2020
3:15 PM
Core Laboratories (Issuer)
van Dijken Eeuwijk Monique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
3:14 PM
Core Laboratories (Issuer)
Klingensmith Harvey Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
3:12 PM
Core Laboratories (Issuer)
van Dijken Eeuwijk Monique (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/19/2020
11:06 AM
Core Laboratories (Issuer)
GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
10:48 AM
Core Laboratories (Issuer)
GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/11/2020
8:52 PM
Core Laboratories (Filer)
Form DEFA14A
05/11/2020
3:14 PM
Core Laboratories (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
05/08/2020
3:24 PM
Core Laboratories (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G/A
05/08/2020
2:25 PM
Core Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
05/08/2020
9:58 AM
BlackRock Inc. (Filed by)
Core Laboratories (Subject)
Form SC 13G/A
04/22/2020
3:47 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2020
1:59 PM
Core Laboratories (Issuer)
van Kempen Margaret Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
1:58 PM
Core Laboratories (Issuer)
Straughen Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
1:56 PM
Core Laboratories (Issuer)
Sodderland Jan Willem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
1:56 PM
Core Laboratories (Issuer)
Hill Christopher Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
1:54 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
1:54 PM
Carnes Martha Z. (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
1:52 PM
Bruno Lawrence (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
1:51 PM
Barnett Gregory Barry (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
3:12 PM
Core Laboratories (Subject)
VAN ECK ASSOCIATES CORP (Filed by)
Form SC 13G/A
03/27/2020
3:05 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2020
3:05 PM
Core Laboratories (Filer)
Form DEFA14A
03/20/2020
1:02 PM
Core Laboratories (Filer)
Form DEFA14A
03/20/2020
12:59 PM
Core Laboratories (Filer)
Form DEF 14A
03/16/2020
4:25 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
1:00 PM
Core Laboratories (Filer)
Form PRE 14A
03/05/2020
3:09 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
11:20 AM
Clearbridge Investments, LLC (Filed by)
Core Laboratories (Subject)
Form SC 13G/A
02/13/2020
11:21 AM
Core Laboratories (Subject)
VAN ECK ASSOCIATES CORP (Filed by)
Form SC 13G
02/12/2020
4:22 PM
Core Laboratories (Issuer)
Hill Christopher Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
4:07 PM
Core Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2020
12:16 PM
Core Laboratories (Subject)
EARNEST PARTNERS LLC (Filed by)
Form SC 13G/A
02/05/2020
12:22 PM
Core Laboratories (Subject)
WCM INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/04/2020
9:57 AM
Bruno Lawrence (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
4:13 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
3:15 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:02 PM
Barnett Gregory Barry (Reporting)
Core Laboratories (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
12/30/2019
4:09 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
8:53 AM
Clearbridge Investments, LLC (Filed by)
Core Laboratories (Subject)
Form SC 13G/A
10/23/2019
3:47 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:03 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
3:06 PM
Barnett Gregory Barry (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
2:06 PM
Core Laboratories (Subject)
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (Filed by)
Form SC 13G/A
07/25/2019
7:47 PM
Core Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2019
4:31 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
3:11 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
2:58 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:56 PM
Core Laboratories (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/29/2019
3:55 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2019
4:02 PM
Core Laboratories (Filer)
Form SD
Specialized Disclosure Report  
05/08/2019
11:40 AM
Core Laboratories (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/24/2019
4:15 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
3:19 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
3:12 PM
Core Laboratories (Issuer)
Sodderland Jan Willem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:11 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:05 PM
Core Laboratories (Issuer)
van Kempen Margaret Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:04 PM
Carnes Martha Z. (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:02 PM
Core Laboratories (Issuer)
Dunlap Charles L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
2:08 PM
Core Laboratories (Filer)
Form DEFA14A
03/20/2019
2:03 PM
Core Laboratories (Filer)
Form DEF 14A
03/12/2019
3:11 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
2:39 PM
Core Laboratories (Filer)
Form PRE 14A
03/06/2019
3:23 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2019
3:18 PM
Core Laboratories (Issuer)
Hill Christopher Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:28 PM
Bruno Lawrence (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:26 PM
Core Laboratories (Issuer)
Hill Christopher Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:24 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:18 PM
Core Laboratories (Issuer)
Elvig Mark F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
2:03 PM
Core Laboratories (Subject)
WCM INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/14/2019
1:31 PM
Clearbridge Investments, LLC (Filed by)
Core Laboratories (Subject)
Form SC 13G/A
02/11/2019
3:51 PM
Core Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/11/2019
10:10 AM
Core Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/04/2019
9:07 AM
BlackRock Inc. (Filed by)
Core Laboratories (Subject)
Form SC 13G/A
01/30/2019
4:20 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
3:22 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
3:20 PM
Bruno Lawrence (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
3:08 PM
Core Laboratories (Issuer)
Elvig Mark F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
3:30 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2018
1:29 PM
Core Laboratories (Issuer)
Sodderland Jan Willem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
4:06 PM
Core Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2018
4:03 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:05 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2018
8:09 AM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
4:19 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
4:17 PM
Core Laboratories (Issuer)
Hill Christopher Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
4:56 PM
Bruno Lawrence (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
3:22 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2018
3:29 PM
Bruno Lawrence (Reporting)
Core Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2018
4:24 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
3:39 PM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2018
4:30 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2018
4:29 PM
Core Laboratories (Filer)
Form 8-K/A
06/27/2018
3:50 PM
Core Laboratories (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2018
4:20 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2018
10:38 AM
Core Laboratories (Issuer)
Daniels Kevin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2018
3:38 PM
Core Laboratories (Filer)
Form SD
Specialized Disclosure Report  
05/29/2018
3:30 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
3:17 PM
Core Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2018
8:20 PM
Core Laboratories (Filer)
Form 8-K/A
04/17/2018
3:41 PM
Core Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.